November 13, 2024 As per the terms of the agreement, Novo Nordisk has gained the right to expand any resulting metabolic-disease products into other therapeutic areas
"As effective as GLP-1 medications are, many people stop taking them because of cost, side effects or simply not wanting to take a drug long-term," said lead author Shelby Sullivan, MD, director of the Endoscopic Bariatric and Metabolic Program at Dartmouth Health Weight Center and professor of medicine, Dartmouth Geisel School of Medicine
These patches prolong the residence time of exosomes at the administration site and maintain the drug stability and concentration
In adults with obesity, Tirzepatide produced substantial and sustained reductions in body weight, with nearly two-thirds of participants losing at least 20% of their baseline weight (Jastreboff, New England Journal of Medicine )
The medication sends a signal to your brain to reduce hunger and increase the feeling of fullness
Single-use vials force wasteful re-opening of new solvent bottles each time